Assessing Metastatic Disease in Advanced Prostate Cancer: It's Time to Change Imaging
J.O. Barentsz, P. Mulders, W. Gerritsen & J.J. Fütterer
European Urology
2017
71(1):93-95
GPU-based RFA simulation for minimally invasive cancer treatment of liver tumours
P. Mariappan, P. Weir, R. Flanagan, P. Voglreiter, T. Alhonnoro, M. Pollari, M. Moche, H. Busse, J.J. Fütterer, H.R. Portugaller, R. Blanco Sequeiros & M. Kolesnik
International Journal of Computer Assisted Radiology and Surgery
2017
12(1):59-68
Comparison of dynamic magnetic resonance defaecography with rectal contrast and conventional defaecography for posterior pelvic floor compartment prolapse
J.J. van Iersel, H.A. Formijne Jonkers, P.M. Verheijen, I.A.M.J. Broeders, B.G.F. Heggelman, V. Sreetharan, J.J. Fütterer, I. Somers, M. van der Leest & E.C.J. Consten
Colorectal Disease
2017
19(1):O46-O53
Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy-Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey
R. Bultijnck, C. Surcel, G. Ploussard, A. Briganti, P. De Visschere, J.J. Fütterer, P. Ghadjar, G. Giannarini, H. Isbarn, C. Massard, P. Sooriakumaran, M. Valerio, R. van den Bergh & P. Ost
European Urology Focus
2016
2(5):514-521
MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience
W.J.M. van de Ven, W. Venderink, J.P.M. Sedelaar, J. Veltman, J.O. Barentsz, J.J. Fütterer, E.B. Cornel & H.J. Huisman
International Urology and Nephrology
2016
48(7):1037-45
Visibility of prostate cancer on transrectal ultrasound during fusion with multiparametric magnetic resonance imaging for biopsy
W.J.M. van de Ven, J.P.M. Sedelaar, M.M.G. van der Leest, C.A. Hulsbergen-van de Kaa, J.O. Barentsz, J.J.Fütterer & H.J. Huisman
Clinical Imaging
2016
40(4):745-50
In vivo MR guided boiling histotripsy in a mouse tumor model evaluated by MRI and histopathology
M. Hoogenboom, D.C. Eikelenboom, M.H. den Brok, A. Veltien, M. Wassink, P. Wesseling, E. Dumont, J.J. Fütterer, G.J. Adema, A. Heerschap
NMR in Biomedicine
2016
29(6):721-31
In-Bore MR-Guided Biopsy Systems and Utility of PI-RADS
J.J. Fütterer, M. Moche, H. Busse & D. Yakar
Topics in Magnetic Resonance Imaging
2016
25(3):119-23
Comparison of translabial three-dimensional ultrasound with magnetic resonance imaging for measurement of levator hiatal biometry at rest
T.F.M. Vergeldt, K.J.B. Notten, J. Stoker, J.J. Fütterer, R.G. Beets-Tan, R.F.A. Vliegen, K.J. Schweitzer, F.E.M. Mulder, S.M.J. van Kuijk, J.P.W.R. Roovers, K.B. Kluivers & M. Weemhoff
Ultrasound in Obstetrics and Gynecology
2016
47(5):636-41
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer
P.J.L. De Visschere, A. Briganti, J.J. Fütterer, P. Ghadjar, H. Isbarn, C. Massard, P. Ost, P. Sooriakumaran, C.I. Surcel, M. Valerio, R.C.N. van den Bergh, G. Ploussard, G. Giannarini & G.M. Villeirs
Insights Imaging
2016
7(2):205-14
Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation
M.J. van Amerongen, E.P. van der Stok, J.J. Fütterer, S.F.M. Jenniskens, A. Moelker, D.J. Grünhagen, C. Verhoef & J.H.W. de Wilt
European Journal of Surgical Oncology
2016
42(4):523-30
Radioembolization dosimetry: the road ahead
M.L.J. Smits, M. Elschot, D.Y. Sze, Y.H. Kao, J.F.W. Nijsen, A.H. Iagaru, H.W.A.M. de Jong, M.A.A.J. van den Bosch & M.G.E.H. Lam
CardioVascular and Interventional Radiology
2015
38(2):261-9
Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer
H. Lepor, E. Llukani, D. Sperling & J.J. Fütterer
European Urology
2015
68(6):924-6
Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation
V. Panebianco, F. Barchetti, J.O. Barentsz, A. Ciardi, F. Cornud, J.J. Fütterer & G. Villeirs
Insights Imaging
2015
6(6):611-30
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
J.J. Fütterer, A. Briganti, P. De Visschere, M. Emberton, G. Giannarini, A. Kirkham, S.S. Taneja, H. Thoeny, G. Villeirs & A. Villers
European Urology
2015
68(6):1045-53
Alginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of Doxorubicin
M. van Elk, B. Ozbakir, A.D. Barten-Rijbroek, G. Storm, J.F.W. Nijsen, W.E. Hennink, T. Vermonden, & R. Deckers
PLoS One
2015
10(11):e0141626
Clinical symptoms related to anal sphincter defects and atrophy on external phased-array MR imaging
I.M.H. Kessels, J.J. Fütterer, A.H. Sultan & K.B. Kluivers
International Urogynecology Journal
2015
26(11):1619-27
Biological Effects After Discontinuation of VEGFR Inhibitors in Metastatic Renal Cell Cancer
M.J. Boers-Sonderen, I.M.E. Desar, J.J. Fütterer, S.F. Mulder, L.F. De Geus-Oei, P.F. Mulders, W.T.A. Van Der Graaf, W.J.G. Oyen & C. M.L. Van Herpen
Anticancer Research
2015
35(10):5601-6
Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project
B.G. Muller, W. van den Bos, M. Brausi, J.J. Fütterer, S. Ghai, P.A. Pinto, I.V. Popeneciu, T.M. de Reijke, C. Robertson, J.J.M.C.H. de la Rosette, S. Scionti, B. Turkbey, H. Wijkstra, O. Ukimura & T.J. Polascik
World Journal of Urology
2015
33(10):1503-9
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives
T.W.J. Scheenen, A.B. Rosenkrantz, M.A. Haider & J.J. Fütterer
Investigative Radiology
2015
50(9):594-600
Will Magnetic Resonance Imaging-guided Biopsy Replace Systematic Biopsy?
J.O. Barentsz, J.J. Fütterer &A.R. Padhani
European Urology Focus
2015
1(2):152-155
Transrectal Ultrasound (US), Contrast-enhanced US, Real-time Elastography, HistoScanning, Magnetic Resonance Imaging (MRI), and MRI-US Fusion Biopsy in the Diagnosis of Prostate Cancer
T.H. Kuru, J.J. Fütterer, J. Schiffmann, D. Porres, G. Salomon & A.R. Rastinehad
European Urology Focus
2015
1(2):117-126
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database
A. Tsikkinis, N. Cihoric, G. Giannarini, S. Hinz, A. Briganti, P. Wust, P. Ost, G. Ploussard, C. Massard, C.I. Surcel, P. Sooriakumaran, H. Isbarn, P.J.L. De Visschere, J.J. Fütterer, R.C.N. van der Bergh, A. Dal Pra, D.M. Aebersold, V. Budach & P. Ghadjar
European Urology Focus
2015
1(2):173-184
Development of a high-field MR-guided HIFU setup for thermal and mechanical ablation methods in small animals
M. Hoogenboom, M.J. van Amerongen, D.C. Eikelenboom, M. Wassink, M.H. den Brok, C. Hulsbergen-van de Kaa, E. Dumont, G.J. Adema, A. Heerschap & J.J. Fütterer
Journal of Therapeutic Ultrasound
2015
3:14
Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma
N. Hugen, C.J. van de Velde, S.L. Bosch, J.J. Fütterer, M.A. Elferink, C.A. Marijnen, H.J. Rutten, J.H. de Wilt & I.D. Nagtegaal
Annals of Surgical Oncology
2015
22(8):2669-76
Location of Prostate Cancers Determined by Multiparametric and MRI-Guided Biopsy in Patients With Elevated Prostate-Specific Antigen Level and at Least One Negative Transrectal Ultrasound-Guided Biopsy
M.G. Schouten, C.M.A. Hoeks, J.G.R. Bomers, C.A. Hulsbergen-van de Kaa, J.A. Witjes, L.C. Thompson, M.M. Rovers, J.O. Barentsz & J.J. Fütterer
America Journal of Roentgenology
2015
205(1):57-63
Mechanical high-intensity focused ultrasound destruction of soft tissue: working mechanisms and physiologic effects
M. Hoogenboom, D. Eikelenboom, M.H. den Brok, A. Heerschap, J.J. Fütterer & G.J. Adema
Ultrasound in Medicine & Biology
2015
41(6):1500-17
Mechanical high-intensity focused ultrasound destruction of soft tissue: working mechanisms and physiologic effects
M. Hoogenboom, D. Eikelenboom, M.H. den Brok, A. Heerschap, J.J. Fütterer & G.J. Adema
Ultrasound in Medicine & Biology
2015
41(6):1500-17
The oncologic role of local treatment in primary metastatic prostate cancer
P. Ghadjar, A. Briganti, P.J.L. De Visschere, J.J. Fütterer, G. Giannarini, H. Isbarn, P. Ost, P. Sooriakumaran, C.I. Surcel, R.C.N. van den Bergh, I.M. van Oort, O. Yossepowitch & G. Ploussard
World Journal of Urology
2015
33(6):755-61
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review
C.I. Surcel, I.M. van Oort, P. Sooriakumaran, A. Briganti, P.J.L. De Visschere, J.J. Fütterer, P. Ghadjar, H. Isbarn, P. Ost, R.C.N. van den Bergh, O. Yossepowitch, G. Giannarini, G. Ploussard & Members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology
Urologic Oncology
2015
33(6):265.e1-7.
Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey
C.I. Surcel, P. Sooriakumaran, A. Briganti, P.J.L. De Visschere, J.J. Fütterer, P. Ghadjar, H. Isbarn, P. Ost, G. Ploussard, R.C.N. van den Bergh, I.M. van Oort, O. Yossepowitch, J.P.M. Sedelaar, G. Giannarini & Members of Prostate Cancer Working Group of Young Academic Urologists Working Party; Members of Young Urologists Office of European Association of Urology
BJU International
2015
115(4):571-9
1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy
L.A. Reisæter, J.J. Fütterer, O.J. Halvorsen, Y. Nygård, M. Biermann, E. Andersen, K. Gravdal, S. Haukaas, J.A. Monssen, H.J. Huisman, L.A. Akslen, C. Beisland & J. Rørvik
Acta Radiologica
2015
56(4):500-11
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series
G. Gandaglia, G. Ploussard, H. Isbarn, N. Suardi, P.J.L. De Visschere, J.J. Fütterer, P. Ghadjar, C. Massard, P. Ost, P. Sooriakumaran, C.I. Surcel, R.C.N. van der Bergh, F. Montorsi, V. Ficarra, G. Giannarini, A. Briganti & Prostate Cancer Working Group of Young Academic Urologists Working Party of European Association of Urology
Urologic Oncology
2015
33(4):164.e1-9
Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling
H. Isbarn, A. Briganti, P.J.L. De Visschere, J.J. Fütterer, P. Ghadjar, G. Giannarini, P. Ost, G. Ploussard, P. Sooriakumaran, C.I. Surcel, I.M. van Oort, O. Yossepowitch, R.C.N. van den Bergh & Prostate Cancer Working Group of the European Association of Urology Young Academic Urologists
Archivos Espanoles de Urologica
2015
68(3):296-306